STUDY OF CORRELATION OF PULSE PRESSURE WITH FRS IN TYPE 2 DIABETES MELLITUS AT A TERTIARY CARE CENTRE IN BANGALORE.

Mahmood SS, Levy D, Vasan RS, et al. The Framingham Heart Study and the epidemiology of cardiovascular diseases: a historical perspective. Lancet 2014;383(9921):999-1008.                          

Bruenn HG. Clinical notes on the illness and death of President Franklin D. Roosevelt. Ann Intern Med 1970;72(4):579-91.          

Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97(18):1837-47.    

Eichler K, Puhan MA, Steurer J, et al. Prediction of first coronary events with the Framingham score: a systematic review. Am Heart J 2007;153(5):722-31, 731.e1-8.                       

Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013;127(1):e6-e245.               

Cockcroft JR, Wilkinson IB, Evans M, et al. Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus. Am J Hypertens 2005;18(11):1463-7, discussion 1468-9.               

Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339(4):229-34.             

Conget I, Gimenez M. Glucose control and cardiovascular disease: is it important? No. Diabetes Care 2009;32(Suppl 2):S334-S6.        

Lichtenstein MJ, Shipley MJ, Rose G. Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study. Br Med J (Clin Res Ed) 1985;291(6490):243-5.               

O’Rourke M, Frohlich ED. Pulse pressure: Is this a clinically useful risk factor? Hypertens 1999;34(3):372-4.            

Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001;103(9):1245-9.           

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Circulation 2002;106(25):3143-421.         

Nawrot TS, Staessen JA, Thijs L, et al. Should pulse pressure become part of the Framingham risk score? J Hum Hypertens 2004;18(4):279-86.  

Kroeker EJ, Wood EH. Comparison of simultaneously recorded central and peripheral arterial pressure pulses during rest, exercise and tilted position in man. Circ Res 1955;3(6):623-32.          

Wilkinson IB, Franklin SS, Hall IR, et al. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension 2001;38(6):1461-6. https://researchers.mq.edu.au/en/publications/pressureamplification-explains-why-pulse-pressure-is-unrelated-t               

Madhavan S, Ooi WL, Cohen H, et al. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertens 1994;23(3):395-401.  

Sesso HD, Stampfer MJ, Rosner B, et al. Systolic and diastolic blood pressure, pulse pressure and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertens 2000;36(5):801-7.      

Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007;30(1):162-72.